Biotron Limited

—As of Sun 8 Nov 2026, 12:00 UTC
ASX:BITHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (24.73%)
Div yield —
ROE (87.44%)
Biotechnology
Beta (5Y) (0.21)
PE TTM —
TSR TTM (50.00%)
Mkt cap A$5.570M
ROIC (56.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0022
10.95%
(56.55%)
Hold 11|2|1|12|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
21.50%
10.30%
12.45%
16.22%
Revenue$M
0.402
0.405
0.419
0.427
8.50%
5.64%
7.29%
6.51%
Peers (US$3.826M)
Cap (US$)
PE
3.645M
—
3.863M
—
Capital
TTM
5Y
10Y
Leveragex
10.17
0.013
0.011
EBIT/Intx
1.438
0.382
0.347
Own earn%
(35.80)
53.26
66.94
Sh yield%
52.58
30.93
26.26
Owners
Insiders/Inst%
2.91
75.88
Short interest%
2.41
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
13–17
$1 testx
−0.1
Incr. ROIC%
19